232 related articles for article (PubMed ID: 3304267)
1. Combined effects of hyperbaric oxygen and antifungal agents on the growth of Candida albicans.
Gudewicz TM; Mader JT; Davis CP
Aviat Space Environ Med; 1987 Jul; 58(7):673-8. PubMed ID: 3304267
[TBL] [Abstract][Full Text] [Related]
2. The influence of antifungal drugs on adherence of Candida albicans to buccal epithelial cells.
Brenciaglia MI; Ghezzi MC; Cipriani P; Mancini C; Trancassini M
Chemioterapia; 1986 Jun; 5(3):200-3. PubMed ID: 3521918
[TBL] [Abstract][Full Text] [Related]
3. Susceptibility to 5-fluorocytosine, miconazole and amphotericin B of Candida albicans strains isolated from the throat of non-AIDS patients.
Paniagua GL; Monroy E; Negrete E; Vaca S
Rev Latinoam Microbiol; 2002; 44(2):65-8. PubMed ID: 17063773
[TBL] [Abstract][Full Text] [Related]
4. The action of miconazole of the growth of Candida albicans.
Van Den Bossche H; Willemsens G; Van Cutsem JM
Sabouraudia; 1975 Mar; 13 Pt 1():63-73. PubMed ID: 1091999
[TBL] [Abstract][Full Text] [Related]
5. [Comparative study of two systems for the determination of the sensitivity of yeasts to antifungal agents].
de Montclos M; de Montclos H; Flandrois JP
Pathol Biol (Paris); 1992 May; 40(5):495-9. PubMed ID: 1495833
[TBL] [Abstract][Full Text] [Related]
6. Effects of imidazole- and triazole-derivative antifungal compounds on the growth and morphological development of Candida albicans hyphae.
Odds FC; Cockayne A; Hayward J; Abbott AB
J Gen Microbiol; 1985 Oct; 131(10):2581-9. PubMed ID: 2999296
[TBL] [Abstract][Full Text] [Related]
7. Synergistic anticandidal activity of xanthorrhizol in combination with ketoconazole or amphotericin B.
Rukayadi Y; Lee K; Lee MS; Yong D; Hwang JK
FEMS Yeast Res; 2009 Dec; 9(8):1302-11. PubMed ID: 19663917
[TBL] [Abstract][Full Text] [Related]
8. Comparison of in vitro activities of amphotericin, clotrimazole, econazole, miconazole, and nystatin against Fusarium oxysporum.
Tzatzarakis MN; Tsatsakis AM; Charvalos E; Vakalounakis D
J Environ Sci Health B; 2001 May; 36(3):331-40. PubMed ID: 11411855
[TBL] [Abstract][Full Text] [Related]
9. [Isolation, identification and drug-resistance of nosocomial yeasts].
Alegente G; Gonnelli A; Galgani P; Boggiano CA
Ann Sclavo; 1982; 24(2):103-13. PubMed ID: 6763853
[No Abstract] [Full Text] [Related]
10. [Incidence of mycotic infections in children with acute myeloblastic leukemia (AML)].
Garavelli PL; Michelone G; Cavanna C; Maccabruni A
Minerva Med; 1988 Apr; 79(4):265-6. PubMed ID: 3163414
[TBL] [Abstract][Full Text] [Related]
11. [Investigation of quantitative and species composition and antifungal drug susceptibility of yeasts isolated from patients with generalized periodontitis complicated by candidosis].
Kutsyk RV; Pavliuk TD
Mikrobiol Z; 2003; 65(5):26-9. PubMed ID: 14723159
[TBL] [Abstract][Full Text] [Related]
12. In vitro susceptibility of oral Candida to seven antifungal agents.
Kuriyama T; Williams DW; Bagg J; Coulter WA; Ready D; Lewis MA
Oral Microbiol Immunol; 2005 Dec; 20(6):349-53. PubMed ID: 16238594
[TBL] [Abstract][Full Text] [Related]
13. [Interactions between 5-fluorocytosine and polyene antibiotics, resp. imidazole derivatives (author's transl)].
Högl F; Raab W
Mykosen; 1981 May; 24(5):261-74. PubMed ID: 6265772
[No Abstract] [Full Text] [Related]
14. In vitro synergic antifungal effect of MUC7 12-mer with histatin-5 12-mer or miconazole.
Wei GX; Bobek LA
J Antimicrob Chemother; 2004 May; 53(5):750-8. PubMed ID: 15073161
[TBL] [Abstract][Full Text] [Related]
15. The effect of antifungal agents on the in vitro susceptibility of Candida albicans to apo-lactoferrin.
Nikawa H; Samaranayake LP; Tenovuo J; Hamada T
Arch Oral Biol; 1994 Oct; 39(10):921-3. PubMed ID: 7741664
[TBL] [Abstract][Full Text] [Related]
16. Comparisons of the susceptibilities of planktonic and adherent Candida albicans to antifungal agents: a modified XTT tetrazolium assay using synchronised C. albicans cells.
Hawser S
J Med Vet Mycol; 1996; 34(2):149-52. PubMed ID: 8732362
[TBL] [Abstract][Full Text] [Related]
17. [Study of the in vitro sensitivity of yeasts with the ATB-Fungus system].
Martínez MM; Mendaza P; Daza RM; Sánchez G; Martín P; Martín JE; Portero F
Rev Esp Quimioter; 1998 Sep; 11(3):251-3. PubMed ID: 9795312
[No Abstract] [Full Text] [Related]
18. [Concentration-contact time relationship in the effect of antimycotic drug combinations (clotrimazole, nystatin, 5-fluorocytosine) and the effect of increasing and decreasing antimycotic drug concentrations on Candida albicans].
Rumler W; Heins S
Mykosen; 1985 May; 28(5):251-7. PubMed ID: 3892290
[No Abstract] [Full Text] [Related]
19. Efficacy of antifungal agents in the cornea. II. Influence of corticosteroids.
O'Day DM; Ray WA; Robinson R; Head WS
Invest Ophthalmol Vis Sci; 1984 Mar; 25(3):331-5. PubMed ID: 6321389
[TBL] [Abstract][Full Text] [Related]
20. Suppression of ATP in Candida albicans by imidazole and derivative antifungal agents.
Odds FC; Cheesman SL; Abbott AB
Sabouraudia; 1985 Dec; 23(6):415-24. PubMed ID: 3913012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
